Document:

Exhibit 10.23

 

IRREVOCABLE PROXY TO
VOTE COMMON STOCK

OF

STRAN & COMPANY,
INC.

 

The undersigned stockholder, and any successors
or assigns (“Stockholder”), of Stran & Company, Inc., a Nevada corporation (the “Company”) hereby
irrevocably (to the fullest extent permitted by applicable law) appoints Andrew Stranberg (such person, the “Proxy”),
or any other designee of Proxy, as the sole and exclusive attorney and proxy of Stockholder, with full power of substitution and resubstitution,
to vote and exercise all voting and related rights (to the fullest extent that Stockholder is entitled to do so) with respect to all of
the shares Common Stock of the Company that now are or hereafter may be beneficially owned by Stockholder, and any and all other shares
or securities of the Company issued or issuable in respect thereof on or after the date hereof (collectively, the “Shares”)
in accordance with the terms of this Irrevocable Proxy. The Shares beneficially owned by Stockholder as of the date of this Irrevocable
Proxy are listed below the Stockholder’s signature on this Irrevocable Proxy. Upon Stockholder’s execution of this Irrevocable
Proxy, any and all prior proxies (other than this Irrevocable Proxy) given Stockholder with respect to the Shares are hereby revoked and
Stockholder agrees not to grant any subsequent proxies with respect to the Shares or enter into any agreement or understanding with any
person to vote or give instructions with respect to such subject matter in any manner inconsistent with the terms of this Irrevocable
Proxy as long as the Shares are outstanding.

 

This Irrevocable Proxy is irrevocable (to the
fullest extent permitted by applicable law), is coupled with an interest sufficient in law to support an irrevocable proxy, is granted
pursuant to that certain Stock Purchase Agreement dated as of even date herewith by and between Andrew Stranberg and Stockholder.

 

The attorney and proxy named above is hereby authorized
and empowered by Stockholder, at any time, to act as Stockholder’s attorney and proxy to vote the Shares, and to exercise all voting
and other rights of Stockholder with respect to the Shares (including, without limitation, the power to execute and deliver written consents),
at every annual, special or adjourned meeting of the stockholders of the Company and in every written consent in lieu of such meeting.

 

All authority herein conferred shall survive the
death or incapacity of Stockholder and any obligation of Stockholder hereunder shall be binding upon the heirs, personal representatives,
successors and assigns of Stockholder.

 

This Irrevocable Proxy is coupled with an interest
as aforesaid and is irrevocable. This Irrevocable Proxy may not be amended or otherwise modified without the prior written consent of
the Stockholder and the Proxy.

 

The Irrevocable Proxy shall automatically terminate
with respect to any Shares that the Stockholder sells in a transaction or series of transactions on any national securities exchange or
other trading market on which the Shares then trade.

 

Dated: May 24, 2021

 

	Theseus Capital
    Ltd.	 
	 	 
	By:	/s/
    Ronald Bauer	 
	 	Ronald Bauer, Authorized
    Representative	 

 

Shares beneficially owned on the date hereof and/or
to be owned following the Closing: 700,000 Shares of Common StockExhibit 10.24

 

INDEPENDENT DIRECTOR AGREEMENT

 

INDEPENDENT DIRECTOR AGREEMENT
(this “Agreement”), dated July 20, 2021, by and between Stran & Company, Inc., a Nevada corporation (the “Company”),
and the undersigned (the “Director”).

 

RECITALS

 

A. The
Company is filing a registration statement on Form S-1 relating to a firm commitment initial public offering of its securities (the “IPO”).

 

B. The
current Board consists of two (2) members and the Board intends to appoint four (4) additional independent directors prior to the closing
of the IPO.

 

C. The
Company desires to appoint the Director to serve on the Company’s board of directors (the “Board”), which will
include membership on one or more committees of the Board, and the Director desires to accept such appointment to serve on the Board.

 

AGREEMENT

 

NOW THEREFORE, in consideration
of the mutual promises contained herein, the adequacy and sufficiency of which are hereby acknowledged, and intending to be legally bound
hereby, the Company and the Director hereby agree as follows:

 

1. Duties.
From and after the effective date of the registration statement for the IPO and related pricing of the IPO (the “Effective Time”),
the Company requires that the Director be available to perform the duties of an independent director customarily related to this function
as may be determined and assigned by the Board and as may be required by the Company’s constituent instruments, including its articles
of incorporation and bylaws, as amended, and its corporate governance and board committee charters, each as amended or modified from time
to time, and by applicable law, including the Nevada Revised Statutes. The Director agrees to devote as much time as is necessary to perform
completely the duties as a Director of the Company, including duties as a member of one or more committees of the Board, to which the
Director may hereafter be appointed. The Director will perform such duties described herein in accordance with the general fiduciary duty
of directors.

 

2. Term.
The term of this Agreement shall commence as of the Effective Time, which shall be the date of the Director’s appointment by the
board of directors of the Company, and shall continue until the Director’s removal or resignation. In addition to a termination
of this Agreement pursuant to Section 8, the Company shall have the right to terminate this Agreement upon written notice to the Director
at any time without liability prior to the Effective Time.

 

     

     

    

 

3. Compensation.

 

(a) Cash
Compensation. Following the commencement of the term of this Agreement, for all services to be rendered by the Director in any capacity
hereunder, the Company agrees to compensate the Director a fee of $[ ] per year in cash (the “Annual Fee”), which Annual
Fee shall be paid to the Director in four (4) equal installments no later than the fifth business day of each calendar quarter commencing
in the first quarter following the Effective Date. The Director shall be responsible for his or her own individual income tax payment
on the Annual Fee in jurisdictions where the Director resides.

 

(b) Equity
Compensation.

 

(i) Upon
execution of this agreement, the Director shall be entitled to receive the Company’s Restricted Common Stock worth $[ ] per year
(the “Share Grants”), which Share Grants shall vest in four (4) equal quarterly installments commencing in the first
quarter following the Effect Date. The per share price of each share issued to the Director shall equal to the price of Company stock
offered in the IPO.

 

(ii) Upon
execution of this agreement, the Director shall be entitled to receive an initial stock option (the “Initial Award”)
to purchase [ ] of the Company’s ordinary shares. The per share exercise price of each option granted to the Director shall equal
to the price of Company stock offered in the IPO. The Initial Award shall vest and become exercisable in twelve (12) equal monthly installments
over the first year following the date of grant, subject to the Director continuing in service on the Board through each such vesting
date. The term of each stock option granted to the Director shall be ten (10) years from the date of grant.

 

In the event that the Director
serves less than a full year on the Board, the Company shall only be obligated to pay the pro rata portion of such Annual Fee to the Director
for his services performed during such year. Furthermore, the vesting of the Option shall not accelerate in the event the Director serves
less than a full year on the Board.

 

4. Independence.
The Director acknowledges that his appointment hereunder is contingent upon the Board’s determination that he is “independent”
with respect to the Company, in accordance with the listing requirements of the Nasdaq and NYSE American stock exchanges, and that his
appointment may be terminated by the Company in the event that the Director does not maintain such independence standard.

 

5. Expenses.
The Company shall reimburse the Director for pre-approved reasonable business related expenses incurred in good faith in connection with
the performance of the Director’s duties for the Company. Such reimbursement shall be made by the Company upon submission by the
Director of a signed statement itemizing the expenses incurred, which shall be accompanied by sufficient documentation to support the
expenditures.

 

    2

     

    

 

6. Other
Agreements.

 

(a) Confidential
Information and Insider Trading. The Company and the Director each acknowledge that, in order for the intentions and purposes of this
Agreement to be accomplished, the Director shall necessarily be obtaining access to certain confidential information concerning the Company
and its affairs, including, but not limited to, business methods, information systems, financial data and strategic plans which are unique
assets of the Company (as further defined below, the “Confidential Information”) and that the communication of such
Confidential Information to third parties could irreparably injure the Company and its business. Accordingly, the Director agrees that,
during his association with the Company and thereafter, he will treat and safeguard as confidential and secret all Confidential Information
received by him at any time and that, without the prior written consent of the Company, he will not disclose or reveal any of the Confidential
Information to any third party whatsoever or use the same in any manner except in connection with the business of the Company and in any
event in no way harmful to or competitive with the Company or its business. For purposes of this Agreement, “Confidential Information”
includes any information not generally known to the public or recognized as confidential according to standard industry practice, any
trade secrets, know-how, development, manufacturing, marketing and distribution plans and information, inventions, formulas, methods or
processes, whether or not patented or patentable, pricing policies and records of the Company (and such other information normally understood
to be confidential or otherwise designated as such in writing by the Company), all of which the Director expressly acknowledges and agrees
shall be confidential and proprietary information belonging to the Company. Upon termination of his association with the Company, the
Director shall return to the Company all documents and papers relating to the Company, including any Confidential Information, together
with any copies thereof, or certify that he or she has destroyed all such documents and papers. Furthermore, the Director recognizes that
the Company has received and in the future will receive confidential or proprietary information from third parties subject to a duty on
the Company’s part to maintain the confidentiality of such information and, in some cases, to use it only for certain limited purposes.
The Director agrees that the Director owes the Company and such third parties, both during the term of the Director’s association
with the Company and thereafter, a duty to hold all such confidential or proprietary information in the strictest confidence and not to,
except as is consistent with the Company’s agreement with the third party, disclose it to any person or entity or use it for the
benefit of anyone other than the Company or such third party, unless expressly authorized to act otherwise by an officer of the Company.
In addition, the Director acknowledges and agrees that the Director may have access to “material non-public information” for
purposes of the federal securities laws (“Insider Information”) and that the Director will abide by all securities
laws relating to the handling of and acting upon such Insider Information.

 

(b) Disparaging
Statements. At all times during and after the period in which the Director is a member of the Board and at all times thereafter, the
Director shall not either verbally, in writing, electronically or otherwise: (i) make any derogatory or disparaging statements about the
Company, any of its affiliates, any of their respective officers, directors, shareholders, employees and agents, or any of the Company’s
current or past customers or employees, or (ii) make any public statement or perform or do any other act prejudicial or injurious to the
reputation or goodwill of the Company or any of its affiliates or otherwise interfere with the business of the Company or any of its affiliates;
provided, however, that nothing in this paragraph shall preclude the Director from complying with all obligations imposed by law or legal
compulsion, and provided, further, however, that nothing in this paragraph shall be deemed applicable to any testimony given by the Director
in any legal or administrative proceedings.

 

(c) Work
Product. Director agrees that any and all Work Product (as defined below) shall be the Company’s sole and exclusive property.
Director hereby irrevocably assigns to the Company all right, title and interest worldwide in and to any deliverables resulting from the
Director’s services as a director to the Company (“Deliverables”), and to any ideas, concepts, processes,
discoveries, developments, formulae, information, materials, improvements, designs, artwork, content, software programs, other copyrightable
works, and any other work product created, conceived or developed by you (whether alone or jointly with others) for the Company during
or before the term of this Agreement, including all copyrights, patents, trademarks, trade secrets, and other intellectual property rights
therein (the “Work Product”). Director retains no rights to use the Work Product and agrees not to challenge
the validity of our ownership of the Work Product. Director agrees to execute, at Company’s request and expense, all documents and
other instruments necessary or desirable to confirm such assignment. In the event that Director does not, for any reason, execute such
documents within a reasonable time after the Company’s request, Director hereby irrevocably appoint the Company as Director’s
attorney-in-fact for the purpose of executing such documents on your behalf, which appointment is coupled with an interest. Director will
deliver to the Company any Deliverables and disclose promptly in writing to us all other Work Product.

 

    3

     

    

 

(d) Enforcement.
The Director acknowledges and agrees that the covenants contained herein are reasonable, that valid consideration has been and will be
received and that the agreements set forth herein are the result of arms-length negotiations between the parties hereto. The Director
recognizes that the provisions of this Section 6 are vitally important to the continuing welfare of the Company and its affiliates and
that any violation of this Section 6 could result in irreparable harm to the Company and its affiliates for which money damages would
constitute a totally inadequate remedy. Accordingly, in the event of any such violation by the Director, the Company and its affiliates,
in addition to any other remedies they may have, shall have the right to institute and maintain a proceeding to compel specific performance
thereof or to obtain an injunction or other equitable relief restraining any action by the Director in violation of this Section 6 without
posting any bond therefore or demonstrating actual damages, and the Director will not claim as a defense thereto that the Company has
an adequate remedy at law or require the posting of a bond. If any of the restrictions or activities contained in this Section 6 shall
for any reason be held by an arbitrator to be excessively broad as to duration, geographical scope, activity or subject, such restrictions
shall be construed so as thereafter to be limited or reduced to be enforceable to the extent compatible with the applicable law; it being
understood that by the execution of this Agreement the parties hereto regard such restrictions as reasonable and compatible with their
respective rights. The Director acknowledges that injunctive relief may be granted immediately upon the commencement of any such action
without notice to the Director and in addition Company may recover monetary damages.

 

(e) Separate
Agreement. The parties hereto further agree that the provisions of Section 6 are separate from and independent of the remainder of
this Agreement and that Section 6 is specifically enforceable by the Company notwithstanding any claim made by the Director against the
Company. The terms of this Section 6 shall survive termination of this Agreement.

 

7. Market
Stand-Off Agreement. In the event of a public or private offering of the Company’s securities, including in connection
with the IPO, and upon request of the Company, the underwriters or placement agents placing the offering of the Company’s securities,
the Director agrees not to sell, make any short sale of, loan, grant any option for the purchase of, or otherwise dispose of any securities
of the Company that the Director may own, other than those included in the registration, without the prior written consent of the Company
or such underwriters, as the case may be, for such period of time from the effective date of such registration as may be requested by
the Company or such placement agent or underwriter.

 

8. Termination.
With or without cause, the Company and the Director may each terminate this Agreement at any time upon ten (10) days written notice, and
the Company shall be obligated to pay to the Director the compensation and expenses due up to the date of the termination. Nothing contained
herein or omitted herefrom shall prevent the stockholder(s) of the Company from removing the Director with immediate effect at any time
for any reason. For the avoidance of doubt, if the Company terminates this Agreement prior to the closing of the IPO in accordance with
Section 2 hereof, then the Company shall not have any liability whatsoever to the Director.

 

9. Indemnification.
The Company shall indemnify, defend and hold harmless the Director, to the full extent allowed by the law of the State of Nevada, and
as provided by, or granted pursuant to, any charter provision, bylaw provision, agreement (including, without limitation, the Indemnification
Agreement executed herewith), vote of stockholders or disinterested directors or otherwise, both as to action in the Director’s
official capacity and as to action in another capacity while holding such office. The Company and the Director are executing an indemnification
agreement in the form attached hereto as Exhibit A.

 

10. Effect
Of Waiver. The waiver by either party of the breach of any provision of this Agreement shall not operate as or be construed
as a waiver of any subsequent breach thereof.

 

    4

     

    

 

11. Notice.
Any and all notices referred to herein shall be sufficient if furnished in writing at the addresses specified on the signature page hereto
or, if to the Company, to the Company’s address as specified in filings made by the Company with the U.S. Securities and Exchange
Commission.

 

12. Governing
Law; Arbitration. This Agreement shall be interpreted in accordance with, and the rights of the parties hereto shall be
determined by, the laws of the State of Nevada without reference to that state’s conflicts of laws principles. Any disputes or claims
arising under or in connection with this Agreement or the transactions contemplated hereunder shall be resolved by binding arbitration.
Notice of a demand to arbitrate a dispute by any party hereto shall be given in writing to the other parties hereto at their last known
addresses. Arbitration shall be commenced by the filing by such a party of an arbitration demand with the American Arbitration Association
(“AAA”). The arbitration and resolution of the dispute shall be resolved by a single arbitrator appointed by the AAA pursuant
to AAA rules. The arbitration shall in all respects be governed and conducted by applicable AAA rules, and any award and/or decision shall
be conclusive and binding on the parties. The arbitration shall be conducted in Scottsdale, Arizona. The arbitrator shall supply a written
opinion supporting any award, and judgment may be entered on the award in any court of competent jurisdiction. Each party hereto shall
pay its own fees and expenses for the arbitration, except that any costs and charges imposed by the AAA and any fees of the arbitrator
for his services shall be assessed against the losing party by the arbitrator. In the event that preliminary or permanent injunctive relief
is necessary or desirable in order to prevent a party from acting contrary to this Agreement or to prevent irreparable harm prior to a
confirmation of an arbitration award, then any party hereto is authorized and entitled to commence a lawsuit solely to obtain equitable
relief against the other such parties pending the completion of the arbitration in a court having jurisdiction over those parties.

 

13. Assignment.
The rights and benefits of the Company under this Agreement shall be transferable, and all the covenants and agreements hereunder shall
inure to the benefit of, and be enforceable by or against, its successors and assigns. The duties and obligations of the Director under
this Agreement are personal and therefore the Director may not assign any right or duty under this Agreement without the prior written
consent of the Company.

 

14. Miscellaneous.
If any provision of this Agreement shall be declared invalid or illegal, for any reason whatsoever, then, notwithstanding such invalidity
or illegality, the remaining terms and provisions of the this Agreement shall remain in full force and effect in the same manner as if
the invalid or illegal provision had not been contained herein. The article headings contained in this Agreement are for reference purposes
only and shall not affect in any way the meaning or interpretation of this Agreement. This Agreement may be executed in any number of
counterparts, each of which shall be deemed an original but all of which taken together shall constitute one and the same instrument.
Counterparts may be delivered via facsimile, electronic mail (including pdf or any electronic signature complying with the U.S. federal
ESIGN Act of 2000, e.g., www.docusign.com) or other transmission method and any counterpart so delivered shall be deemed to have
been duly and validly delivered and be valid and effective for all purposes. Except as provided elsewhere herein, this Agreement sets
forth the entire agreement of the parties with respect to its subject matter and supersedes all prior agreements, promises, covenants,
arrangements, communications, representations or warranties, whether oral or written, by any officer, employee or representative of any
party to this Agreement with respect to such subject matter.

 

[Signature Page Follows]

 

    5

     

    

 

IN WITNESS WHEREOF, the parties
hereto have caused this Independent Director Agreement to be duly executed and signed as of the day and year first above written.

 

	 	COMPANY:
	 	 
	 	Stran & Company, Inc.
	 	 	 
	 	By:	 
	 	Name:	Andy Shape
	 	Title:	Chief Executive Officer
	 	 	 
	 	DIRECTOR:
	 	 
	 	 
	 	Name:
	 	Address:

 

     

     

    

 

EXHIBIT A

 

Indemnification Agreement

(See Attached)

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00334-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00334-of-00352.parquet"}]]